Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,922,834
+$203,916 QoQ
Shares Held
23,321
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#1,487
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PALISADE CAPITAL MANAGEMENT, LP holds $44,577,032 across 7 Drug Manufacturers - General names. JNJ ranks #3 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
70,905 | $17,842,534 | |
| 2 | LLY |
ELI LILLY & Co
|
12,084 | $14,493,913 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
23,321 | $5,922,834 | |
| 4 | NVO |
Novo Nordisk A S
|
113,575 | $5,444,785 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,742 | $346,424 | |
| 6 | AZN |
Astrazeneca PLC
|
1,412 | $267,743 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,014 | $258,799 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,922,834 | 23,321 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,718,918 | 23,396 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,777,647 | 23,086 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,370,349 | 23,570 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,615,287 | 23,668 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,946,660 | 23,798 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $3,714,564 | 25,685 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,522,680 | 34,078 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,220,476 | 56,243 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,477,710 | 78,878 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,102,211 | 89,972 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,931,837 | 89,450 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,158,321 | 91,580 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,196,915 | 91,593 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $16,284,656 | 92,186 | Shares | Sole | 2023-03-24 | |
| 2022-09-30 | $15,030,263 | 92,007 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,529,376 | 93,118 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $16,507,379 | 93,141 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $15,890,863 | 92,891 | Shares | Sole | 2022-04-21 | |
| 2021-09-30 | $14,925,022 | 92,415 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $15,320,655 | 92,999 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $15,345,688 | 93,372 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $14,436,467 | 91,730 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $13,616,267 | 91,458 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $12,015,005 | 85,437 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $10,573,405 | 80,633 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||